NASDAQ:PRVA Privia Health Group (PRVA) Stock Price, News & Analysis → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free PRVA Stock Alerts $17.53 -0.52 (-2.88%) (As of 02:46 PM ET) Add Compare Share Share Today's Range$17.52▼$18.5050-Day Range$17.69▼$22.9252-Week Range$16.90▼$29.42Volume500,159 shsAverage Volume954,223 shsMarket Capitalization$2.09 billionP/E Ratio116.87Dividend YieldN/APrice Target$25.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Privia Health Group alerts: Email Address Privia Health Group MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.83 Rating ScoreUpside/Downside42.6% Upside$25.33 Price TargetShort InterestBearish5.75% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.23Based on 35 Articles This WeekInsider TradingSelling Shares$897,700 Sold Last QuarterProj. Earnings Growth37.50%From $0.24 to $0.33 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.37 out of 5 starsMedical Sector130th out of 928 stocksHealth Services Industry1st out of 10 stocks 4.4 Analyst's Opinion Consensus RatingPrivia Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 10 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoveragePrivia Health Group has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Privia Health Group's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted5.75% of the float of Privia Health Group has been sold short.Short Interest Ratio / Days to CoverPrivia Health Group has a short interest ratio ("days to cover") of 6.4.Change versus previous monthShort interest in Privia Health Group has recently decreased by 4.25%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldPrivia Health Group does not currently pay a dividend.Dividend GrowthPrivia Health Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PRVA. Previous Next 1.8 News and Social Media Coverage News SentimentPrivia Health Group has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 35 news articles for Privia Health Group this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for PRVA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $897,700.00 in company stock.Percentage Held by Insiders14.20% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions94.48% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Privia Health Group's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Privia Health Group are expected to grow by 37.50% in the coming year, from $0.24 to $0.33 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Privia Health Group is 118.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.61.Price to Earnings Ratio vs. SectorThe P/E ratio of Privia Health Group is 118.40, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 135.66.Price to Earnings Growth RatioPrivia Health Group has a PEG Ratio of 2.39. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrivia Health Group has a P/B Ratio of 3.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Privia Health Group's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIMost people would never touch this orange powder… would you? At first glance, it looks like some ordinary “orange” powder… But in reality, it is a scientific breakthrough in energy technology. One that could wipe out fossil fuel, coal, and even the “glorified” renewable energy in just a few years. And right now, governments, institutions, and the elites are jumping on this resource at record pace to the point where we’re starting to run out. The question is… Why are the top 1% piling in this much? And more importantly, what will be the implications of this act by the elites on YOU and of course, the stock market?Well, all the answers you need are right here About Privia Health Group Stock (NASDAQ:PRVA)Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.Read More PRVA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRVA Stock News HeadlinesMay 14 at 5:39 AM | insidertrades.comPrivia Health Group, Inc. (NASDAQ:PRVA) EVP Thomas Bartrum Sells 1,506 SharesMay 3, 2024 | insidertrades.comInsider Selling: Privia Health Group, Inc. (NASDAQ:PRVA) EVP Sells 2,252 Shares of StockMay 14 at 9:47 AM | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), IN8bio (INAB) and Privia Health Group (PRVA)May 14 at 6:19 AM | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra Sells 13,869 SharesMay 14 at 5:40 AM | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle Sells 2,232 Shares of StockMay 14 at 5:40 AM | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) EVP Thomas Bartrum Sells 1,506 Shares of StockMay 13 at 6:46 PM | finance.yahoo.comPrivia Health Group, Inc. (NASDAQ:PRVA) Q1 2024 Earnings Call TranscriptMay 13 at 1:50 AM | americanbankingnews.comQ2 2024 EPS Estimates for Privia Health Group, Inc. (NASDAQ:PRVA) Lifted by AnalystMay 13 at 1:50 AM | americanbankingnews.comResearch Analysts Offer Predictions for Privia Health Group, Inc.'s Q2 2024 Earnings (NASDAQ:PRVA)May 12 at 5:32 AM | americanbankingnews.comPrivia Health Group (NASDAQ:PRVA) Price Target Cut to $26.00May 10, 2024 | finance.yahoo.comPrivia Health Group Inc (PRVA) Q1 2024 Earnings: Mixed Results Amid Operational GrowthMay 10, 2024 | finance.yahoo.comPrivia Health Group First Quarter 2024 Earnings: EPS: US$0.025 (vs US$0.064 in 1Q 2023)May 9, 2024 | finanznachrichten.dePrivia Health Group, Inc.: Privia Health Reports First Quarter 2024 Financial ResultsMay 9, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for Privia Health Group Amid Strong Financial Performance and Positive Growth OutlookMay 9, 2024 | markets.businessinsider.comPrivia Health Q1 Net Profit More Than Halves; Backs FY24 Revenue OutlookMay 9, 2024 | msn.comPrivia Health Group Non-GAAP EPS of $0.18 beats by $0.03, revenue of $415.2M beats by $20.45MMay 9, 2024 | seekingalpha.comPrivia Health Group, Inc. 2024 Q1 - Results - Earnings Call PresentationMay 9, 2024 | globenewswire.comPrivia Health Reports First Quarter 2024 Financial ResultsMay 3, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on Privia Health Group (PRVA)April 22, 2024 | msn.comCitigroup Initiates Coverage of Privia Health Group (PRVA) with Buy RecommendationApril 22, 2024 | markets.businessinsider.comWhere Privia Health Gr Stands With AnalystsApril 9, 2024 | globenewswire.comPrivia Health to Report First Quarter 2024 Results on Thursday, May 9April 4, 2024 | finance.yahoo.comPRVA: Rating increased to a HOLDMarch 19, 2024 | markets.businessinsider.comAnalyst Scoreboard: 8 Ratings For Privia Health GrMarch 6, 2024 | markets.businessinsider.comJP Morgan Maintains Overweight Rating for Privia Health Gr: Here's What You Need To KnowSee More Headlines Receive PRVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today5/15/2024Next Earnings (Estimated)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:PRVA CUSIPN/A CIK1759655 Webwww.priviahealth.com Phone571-366-8850FaxN/AEmployees1,102Year FoundedN/APrice Target and Rating Average Stock Price Target$25.33 High Stock Price Target$30.00 Low Stock Price Target$21.00 Potential Upside/Downside+44.5%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)$0.15 Trailing P/E Ratio118.40 Forward P/E Ratio74.00 P/E Growth2.39Net Income$23.08 million Net Margins1.11% Pretax Margin1.44% Return on Equity3.13% Return on Assets1.89% Debt Debt-to-Equity RatioN/A Current Ratio1.80 Quick Ratio1.80 Sales & Book Value Annual Sales$1.66 billion Price / Sales1.28 Cash Flow$0.25 per share Price / Cash Flow71.73 Book Value$5.22 per share Price / Book3.40Miscellaneous Outstanding Shares119,320,000Free Float102,375,000Market Cap$2.12 billion OptionableOptionable Beta0.81 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Parth Mehrotra (Age 45)CEO & Director Comp: $1.19MMr. David Mountcastle CPA (Age 54)MBA, Executive VP, CFO & Principal Accounting Officer Comp: $713.72kMr. Thomas Bartrum (Age 56)Executive Officer Comp: $533.02kMr. Chris VoigtExecutive VP & Chief Technology OfficerMr. Robert P. BorchertSenior Vice President of Investor Relations & Corporate CommunicationsMs. Dana Fields CPASenior VP of Internal Audit & Chief Compliance OfficerMr. Edward Christopher Fargis Esq.Executive VP, General Counsel, Chief Legal Officer & Corporate SecretaryMs. Jenny HardingChief People OfficerMr. Jay StevensSenior VP & Chief Growth OfficerMr. Eric J. BeyerExecutive Vice President of Medical GroupsMore ExecutivesKey CompetitorsApollo MedicalNASDAQ:AMEHMagellan HealthNASDAQ:MGLNU.S. Physical TherapyNYSE:USPHLifeStance Health GroupNASDAQ:LFSTAlignment HealthcareNASDAQ:ALHCView All CompetitorsInsiders & InstitutionsSenator Investment Group LPSold 200,000 shares on 5/15/2024Ownership: 0.670%UniSuper Management Pty LtdBought 23,762 shares on 5/13/2024Ownership: 0.020%Ironwood Investment Counsel LLCSold 17,138 shares on 5/11/2024Ownership: 0.014%Covestor LtdBought 1,076 shares on 5/11/2024Ownership: 0.004%Vanguard Group Inc.Bought 121,701 shares on 5/10/2024Ownership: 9.607%View All Insider TransactionsView All Institutional Transactions PRVA Stock Analysis - Frequently Asked Questions Should I buy or sell Privia Health Group stock right now? 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last twelve months. There are currently 2 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PRVA shares. View PRVA analyst ratings or view top-rated stocks. What is Privia Health Group's stock price target for 2024? 12 brokerages have issued twelve-month target prices for Privia Health Group's stock. Their PRVA share price targets range from $21.00 to $30.00. On average, they anticipate the company's stock price to reach $25.33 in the next year. This suggests a possible upside of 42.6% from the stock's current price. View analysts price targets for PRVA or view top-rated stocks among Wall Street analysts. How have PRVA shares performed in 2024? Privia Health Group's stock was trading at $23.03 at the beginning of 2024. Since then, PRVA stock has decreased by 22.9% and is now trading at $17.76. View the best growth stocks for 2024 here. When is Privia Health Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 1st 2024. View our PRVA earnings forecast. How were Privia Health Group's earnings last quarter? Privia Health Group, Inc. (NASDAQ:PRVA) posted its earnings results on Tuesday, February, 27th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by $0.02. The firm had revenue of $440.80 million for the quarter, compared to analyst estimates of $425.81 million. Privia Health Group had a trailing twelve-month return on equity of 3.13% and a net margin of 1.11%. The business's revenue was up 21.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.14 earnings per share. What ETFs hold Privia Health Group's stock? ETFs with the largest weight of Privia Health Group (NASDAQ:PRVA) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Fidelity Disruptive Medicine ETF (FMED), BNY Mellon Innovators ETF (BKIV), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and Harbor Corporate Culture Small Cap ETF (HAPS).iShares U.S. Healthcare Providers ETF (IHF). What guidance has Privia Health Group issued on next quarter's earnings? Privia Health Group issued an update on its FY 2024 earnings guidance on Thursday, May, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.6 billion. When did Privia Health Group IPO? Privia Health Group (PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are Privia Health Group's major shareholders? Privia Health Group's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.61%), Riverbridge Partners LLC (4.55%), Principal Financial Group Inc. (2.89%), Senator Investment Group LP (0.67%), WCM Investment Management LLC (0.48%) and Sei Investments Co. (0.39%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle, Jeffrey B Butler, Jeffrey Daniel Bernstein, Matthew Shawn Morris, Pamplona Capital Partners Iii,, Parth Mehrotra, Thomas Bartrum and William M Sullivan. View institutional ownership trends. How do I buy shares of Privia Health Group? Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PRVA) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyDoes this make you sick?Allegiance Goldis this a buy and hold stock?Tips4TradersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
